Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s ...

(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

Pulmonx Corporation (Nasdaq: LUNG) ('Pulmonx”), a global leader in minimally invasive treatments for lung disease, today ...

Coughing up phlegm feels gross, especially if you’re already dealing with other unpleasant symptoms from a cold or other ...

After Asha Bhosle’s death from chest infection, doctors explain symptoms, warning signs, stages and treatment, especially ...

(Yicai) April 13 -- Shares of Haisco Pharmaceutical Group rose after the Chinese drugmaker granted US peer AbbVie the global ...

Biologics represent a breakthrough in the management of airway diseases, offering precision treatments that target specific immune pathways. This special issue, Biologics for Airway Diseases: From ...

Scott Brooks, from Maltby, was just 17 when he started smoking, saying it was just "the norm" for the 1980s. But after ...

Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...

(RTTNews) - GSK plc (GSK) on Friday said the European Commission has approved Nucala as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD). The ...

NORTH PHILADELPHIA (WPVI) -- There's a potential new treatment for severe emphysema, and Philadelphia is a key test site for this small device with big potential to improve lives. In COPD (Chronic ...